Intellia Therapeutics, Inc. financial data

Symbol
NTLA on Nasdaq
Location
40 Erie Street, Suite 130, Cambridge, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 790 % -16.9%
Debt-to-equity 22.5 %
Return On Equity -52 % -28.4%
Return On Assets -42.4 % -26.2%
Operating Margin -1.25K % -33.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 102M shares +13.7%
Common Stock, Shares, Outstanding 102M shares +14.3%
Common Stock, Value, Issued 10K USD +11.1%
Weighted Average Number of Shares Outstanding, Basic 101M shares +13.9%
Weighted Average Number of Shares Outstanding, Diluted 101M shares +13.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 43.1M USD -16.8%
Research and Development Expense 458M USD +7.58%
General and Administrative Expense 122M USD +10.1%
Costs and Expenses 581M USD +8.11%
Operating Income (Loss) -538M USD -10.8%
Net Income (Loss) Attributable to Parent -522M USD -12.9%
Earnings Per Share, Basic -5.45 USD/shares -2.25%
Earnings Per Share, Diluted -5.45 USD/shares -2.25%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 120M USD -28.3%
Marketable Securities, Current 538M USD -21.7%
Accounts Receivable, after Allowance for Credit Loss, Current 8.85M USD +36.4%
Assets, Current 711M USD -20.4%
Property, Plant and Equipment, Net 28.8M USD -14.9%
Operating Lease, Right-of-Use Asset 100M USD -15.5%
Assets 1.17B USD -5.63%
Accounts Payable, Current 13.1M USD +270%
Employee-related Liabilities, Current 20.6M USD -2.17%
Accrued Liabilities, Current 51.2M USD -11.7%
Contract with Customer, Liability, Current 22.2M USD +66%
Liabilities, Current 106M USD +14.9%
Contract with Customer, Liability, Noncurrent 22.6M USD +77.7%
Operating Lease, Liability, Noncurrent 82.4M USD -18.6%
Liabilities 211M USD +2.33%
Accumulated Other Comprehensive Income (Loss), Net of Tax 3.3M USD
Retained Earnings (Accumulated Deficit) -2.05B USD -34.2%
Stockholders' Equity Attributable to Parent 963M USD -7.21%
Liabilities and Equity 1.17B USD -5.63%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -121M USD -10.4%
Net Cash Provided by (Used in) Financing Activities 60M USD +2601%
Net Cash Provided by (Used in) Investing Activities 5.9M USD
Common Stock, Shares Authorized 240M shares 0%
Common Stock, Shares, Issued 102M shares +14.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -54.8M USD +76.1%
Payments to Acquire Property, Plant, and Equipment 2.51M USD -34.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -518M USD -13.3%
Operating Lease, Liability, Current 19.2M USD +12.3%
Depreciation, Depletion and Amortization 2.51M USD +22.5%
Share-based Payment Arrangement, Expense 150M USD +21.1%